http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014527513-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
| filingDate | 2012-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014527513-A |
| titleOfInvention | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation |
| abstract | The present invention relates to a pharmaceutical composition for the treatment, prevention or amelioration of premature ejaculation, which is taken before sexual intercourse as necessary, characterized in that it contains 14-16 mg, preferably about 15 mg of clomipramine hydrochloride as an active ingredient. To do. More desirably, the compositions of the present invention also include alpha starch (pregelatinized starch) and sodium starch glycolate. The pharmaceutical composition of the present invention has a rapid onset of effects, a small elution (absorption) deviation according to the pH of the gastrointestinal tract of the patient, and very few side effects. [Selection figure] None |
| priorityDate | 2011-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.